论文部分内容阅读
目的:观察丹红注射液联合氯吡格雷治疗进展性卒中的疗效。方法:将96例病人随机分为治疗组和对照组,两组均予常规治疗,治疗组采用丹红注射液及氯吡格雷治疗,对照组仅予氯吡格雷治疗。两组均连续治疗14天后评定疗效及神经功能缺损评分等。结果:治疗组总有效率为87.5%,对照组为77.1%,两组比较有统计学意义(P<0.05)。两组治疗后第7天、第14天时神经功能缺损均较治疗前改善明显(P<0.05),且治疗组优于对照组(P<0.05)。结论:丹红注射液联合氯吡格雷治疗进展性卒中疗效优于单用氯吡格雷。
Objective: To observe the effect of Danhong injection combined with clopidogrel in the treatment of advanced stroke. Methods: Ninety-six patients were randomly divided into treatment group and control group. Both groups were given routine treatment. Danhong injection and clopidogrel were used in the treatment group and clopidogrel only in the control group. Two groups were treated for 14 days after the assessment of efficacy and neurological deficit score. Results: The total effective rate was 87.5% in the treatment group and 77.1% in the control group, with statistical significance (P <0.05). The neurological deficits on the 7th day and the 14th day after treatment were significantly improved in both groups (P <0.05), and the treatment group was better than the control group (P <0.05). Conclusion: Danhong injection plus clopidogrel is superior to clopidogrel alone in the treatment of advanced stroke.